53. Pagliuca G, Rosato C, Martellucci S, et al. Cytologic and functional alterations of nasal mucosa in smokers: temporary or permanent damage?
54. Scheperjans F, Pekkonen E, Kaakkola S, Auvinen P. Linking smoking, coffee, urate, and Parkinson’s disease – a role for gut microbiota?
55. Hopfner F, Kunstner A, Muller SH, et al. Gut microbiota in Parkinson disease in a northern German cohort.
56. Scheperjans F, Pekkonen E, Kaakkola S, Auvinen P. Linking Smoking, Coffee, Urate, and Parkinson’s Disease – A Role for Gut Microbiota?
57. Sampson TR, Debelius JW, Thron T, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease.
58. Там же.
59. Health risks of smoking tobacco. American Cancer Society. Cancer A-Z. www.cancer.org/ cancer/cancer-causes/tobacco-and-cancer/health-risks-of-smoking-tobacco.html. Accessed February 15, 2019.
60. Dorsey ER, Sherer T, Okun M, Bloem BR. The emerging evidence of the Parkinson pandemic.
61. Morris AD, Rose FC.
62. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change.
63. Fauci AS, Morens DM, Folkers GK. What is a Pandemic?
64. Black death. Wikipedia. https://en.wikipedia.org/wiki/Black_Death. Accessed February 15, 2019.
65. Barry JM.
66. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
67. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change.
68. Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases.
69. Allen L. Are we facing a noncommunicable disease pandemic?
70. Fauci AS, Morens DM, Folkers GK. What is a Pandemic?
71. GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.
72. Там же.
73. Gage H, Hendricks A, Zhang S, Kazis L. The relative health related quality of life of veterans with Parkinson’s disease.
74. Kochanek KD, Murphy SL, Xu J, Tejada-Vera B.